1,731
Views
8
CrossRef citations to date
0
Altmetric
Review

Pathogenesis guided therapeutic management of COVID-19: an immunological perspective

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 54-71 | Received 21 Jun 2020, Accepted 17 Oct 2020, Published online: 28 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Matthew W McCarthy. (2023) Optimizing the use of vilobelimab for the treatment of COVID-19. Expert Opinion on Biological Therapy 23:9, pages 877-881.
Read now

Articles from other publishers (7)

Michelle Teixeira de Almeida, Ana Paula Barbosa, Camila Gasque Bomfim, Aline Biazola Visnardi, Tania Churasacari Vinces, Alexandre Ceroni, Edison Luiz Durigon & Cristiane Rodrigues Guzzo. (2023) Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development. Journal of Immunological Methods 522, pages 113558.
Crossref
Jia Yi, Jiameng Miao, Qingwei Zuo, Felix Owusu, Qiutong Dong, Peizhe Lin, Qilong Wang, Rui Gao, Xianbin Kong & Long Yang. (2022) COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. Frontiers in Immunology 13.
Crossref
Ashutosh Kumar, Rakesh Parashar, Sujeet Kumar, Muneeb A Faiq, Chiman Kumari, Maheswari Kulandhasamy, Ravi K. Narayan, Rakesh K. Jha, Himanshu N. Singh, Pranav Prasoon, Sada N. Pandey & Kamla Kant. (2021) Emerging SARS‐CoV‐2 variants can potentially break set epidemiological barriers in COVID‐19. Journal of Medical Virology 94:4, pages 1300-1314.
Crossref
Anolin Aslan, Cynthia Aslan, Naime Majidi Zolbanin & Reza Jafari. (2021) Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia 13:1.
Crossref
Ashutosh Kumar, Ravi K. Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, Maheswari Kulandhasamy, Kishore Sesham, Vikas Pareek, Muneeb A. Faiq, Sada N. Pandey, Himanshu N. Singh, Kamla Kant, Prakash S. Shekhawat, Khursheed Raza & Sujeet Kumar. (2021) COVID-19 Mechanisms in the Human Body—What We Know So Far. Frontiers in Immunology 12.
Crossref
Vamika Karn, Shaista Ahmed, Lung-Wen Tsai, Rajni Dubey, Shreesh Ojha, Himanshu Singh, Mukesh Kumar, Piyush Gupta, Soumi Sadhu, Niraj Jha, Ashutosh Kumar, Soumya Pandit & Sanjay Kumar. (2021) Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 9:10, pages 1373.
Crossref
Ashutosh Kumar, Ravi K. Narayan, Maheswari Kulandhasamy, Pranav Prasoon, Chiman Kumari, Sujeet Kumar, Vikas Pareek, Kishore Sesham, Prakash S. Shekhawat, Kamla Kant & Santosh Kumar. (2021) COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes. Expert Reviews in Molecular Medicine 23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.